Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183118 · ClinicalTrials.gov registry record · Phase 1
Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 180
- Enrollment target
NCT00183118 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 180 participants.
The verdict
NCT00183118, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
Interventions
- BEHAVIORAL Adapted Enhanced-RESPECT (HIV prevention intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183118
The ClinicalTrials.gov registry entry for NCT00183118 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adapted Enhanced-RESPECT (HIV prevention intervention) is the first listed.
NCT00183118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183118 about?
NCT00183118 is a clinical study titled "Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)". The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
What is the current status of trial NCT00183118?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 180 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00183118?
The interventions under investigation include: Adapted Enhanced-RESPECT (HIV prevention intervention) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183118?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.